newsfilter
← Latest News
Business Wire·

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

-Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief- Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing non-addictive